Maybe, I don’t recall. Only listed the once while driving. He may have said ccr5 also, but I was trying to give new investors a 50,000 ft view without too much science needed to understand.

For the trial, it would be nice to just wrap all in one instead of each individual cancer. Also, I could see some massive investor interest if such a trial gets approved, assuming the new patients in mtnbc have similar results to patient #1.